These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38022687)

  • 1. Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer.
    Liu Y; Liu S; Yan L; Zhang Q; Liu W; Huang X; Liu S
    Mediators Inflamm; 2023; 2023():1400267. PubMed ID: 38022687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
    Zheng P; Li N; Zhan X
    Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
    Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
    BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the expression and prognostic significance of m
    Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
    Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y; Li J; Wu J
    BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of m5C RNA Modification Patterns in Biochemical Recurrence and Tumor Microenvironment Characterization of Prostate Adenocarcinoma.
    Xu Z; Chen S; Zhang Y; Liu R; Chen M
    Front Immunol; 2022; 13():869759. PubMed ID: 35603206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
    Fei H; Han X; Wang Y; Li S
    J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
    Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K
    Front Immunol; 2021; 12():800268. PubMed ID: 34956238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment.
    Pan W; Liu X; Liu S
    Medicine (Baltimore); 2024 Apr; 103(14):e37590. PubMed ID: 38579085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data.
    You Y; Yang Q
    BMC Cancer; 2024 Feb; 24(1):207. PubMed ID: 38355446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
    Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
    Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer.
    Hua T; Liu DX; Zhang XC; Li ST; Yan P; Zhao Q; Chen SB
    Front Immunol; 2023; 14():1151109. PubMed ID: 37063862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a new molecular subtyping and prognostic signature with m6A/m5C/m1A/m7G regulatory genes for hepatocellular carcinoma.
    Liu T; Wang Y; Li Z; Sun L; Yang K; Chen J; Han X; Qi L; Zhou X; Wang P
    Heliyon; 2023 Nov; 9(11):e21285. PubMed ID: 38027812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of m5c-related lncRNA risk model for ovarian cancer.
    Wang C; Zhang C; Yang S; Xiang J; Zhou D; Xi X
    J Ovarian Res; 2023 May; 16(1):96. PubMed ID: 37183262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: One step closer to precision medicine.
    Chen B; Xi Y; Zhao J; Hong Y; Tian S; Zhai X; Chen Q; Ren X; Fan L; Xie X; Jiang C
    Front Immunol; 2022; 13():1049435. PubMed ID: 36532062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer.
    Xu X; Wu Y; Jia G; Zhu Q; Li D; Xie K
    J Ovarian Res; 2023 Jan; 16(1):5. PubMed ID: 36611197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single‑cell RNA sequencing reveals heterogeneity in ovarian cancer and constructs a prognostic signature for prognostic prediction and immunotherapy.
    Zhou S; Li H; Zhao C; Zhao W; Pan X; Jian W; Wang J
    Int Immunopharmacol; 2024 Oct; 140():112855. PubMed ID: 39133955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma.
    Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K
    Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.